Silexion Therapeutics (SLXN) Stock Chart & Stock Price History $0.80 0.00 (-0.55%) Closing price 07/3/2025 03:42 PM EasternExtended Trading$0.81 +0.01 (+0.62%) As of 07/3/2025 04:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock Silexion Therapeutics Stock Price Performance The Silexion Therapeutics (SLXN) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock decreased 60.15%. In the past month, the stock has decreased 15.68%, reflecting recent market activity. As of the latest close, Silexion Therapeutics traded at $0.80 with a market cap of $6.96 million and volume of 107,001 shares. Receive SLXN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Silexion Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.25%1 Month Performance-15.68%3 Month Performance-7.15%Year-To-Date Performance-60.15% SLXN Stock Chart for Friday, July, 4, 2025 SLXN Chart by TradingView Silexion Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/03/2025$0.81$0.80-0.55%$0.82$0.79107,001 shs$6.96 million07/02/2025$0.80$0.81+0.39%$0.82$0.7860,570 shs$7.00 million07/01/2025$0.81$0.80-0.95%$0.82$0.7946,687 shs$6.97 million06/30/2025$0.80$0.81+1.38%$0.82$0.7950,121 shs$7.04 million06/27/2025$0.81$0.80-1.48%$0.82$0.7952,659 shs$6.94 million06/26/2025$0.80$0.81+1.38%$0.82$0.76174,604 shs$7.05 million06/25/2025$0.82$0.80-2.44%$0.83$0.7886,408 shs$6.95 million06/24/2025$0.82$0.82+0.49%$0.84$0.8081,493 shs$7.13 million06/23/2025$0.82$0.82+0.12%$0.83$0.8056,968 shs$7.09 million06/20/2025$0.82$0.82-0.61%$0.83$0.78147,616 shs$7.08 million Get the Latest News and Ratings for SLXN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Silexion Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/19/2025$0.82$0.82$0.85$0.8099,071 shs$7.13 million06/18/2025$0.81$0.82+1.77%$0.85$0.8099,071 shs$7.13 million06/17/2025$0.84$0.81-4.08%$0.86$0.80256,629 shs$7.00 million06/16/2025$0.87$0.84-3.96%$0.87$0.84101,204 shs$7.30 million06/13/2025$0.89$0.87-1.24%$0.89$0.83137,323 shs$7.60 million06/12/2025$0.91$0.89-2.87%$0.93$0.88216,546 shs$7.70 million06/11/2025$0.94$0.91-3.00%$0.95$0.90176,536 shs$7.93 million06/10/2025$0.93$0.94+0.61%$0.95$0.92144,250 shs$8.17 million06/09/2025$0.95$0.93-1.22%$0.96$0.92232,974 shs$8.12 million06/06/2025$0.92$0.95+2.64%$0.96$0.92258,079 shs$8.22 million06/05/2025$0.95$0.92-2.99%$0.95$0.88301,308 shs$8.01 million06/04/2025$0.95$0.95-0.06%$0.98$0.92274,187 shs$8.26 million06/03/2025$0.96$0.95-0.99%$0.99$0.94119,426 shs$8.26 million Related Companies Dyadic International Stock Price Chart FibroBiologics Stock Price Chart Coeptis Therapeutics Stock Price Chart KALA BIO Stock Price Chart ALX Oncology Stock Price Chart Enlivex Therapeutics Stock Price Chart Generation Bio Stock Price Chart Tempest Therapeutics Stock Price Chart Dare Bioscience Stock Price Chart Synergy CHC Stock Price Chart Receive SLXN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Silexion Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SLXN) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored“E.I.”- The biggest prediction of my career?One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Silexion Therapeutics Corp Please log in to your account or sign up in order to add this asset to your watchlist. Share Silexion Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
